<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_JMU_Wuerzburg_Description skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:JMU Wuerzburg/Description</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P>Home</P><LI class="menu"><P>Team</P></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Team">Team Members</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Collaborations">Collaborations</A></LI><LI class="menu"><P>Project</P></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Description">Description</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Applied_Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Introduction_Malaria">Introduction to Malaria</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Experiments">Experiments</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Notebook">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/InterLab">InterLab</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Results">Results</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Attributions">Attributions</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Sponsors">Sponsors</A></LI><LI class="menu"><P>Parts</P></LI><LI class="menu"><P>Safety</P></LI><LI class="menu"><P>Human Practices</P></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Human_Practices#workshops">Workshops</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Human_Practices#education">Education</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Human_Practices#establishing">Establishing an iGEM-Team</A></LI><LI><A href="https://2018.igem.org/Team:JMU_Wuerzburg/Human_Practices#collabs">Collaborations for our Laboratory Work</A></LI><LI class="menu"><P>Judging Form</P></LI><DIV class="content"><H3>Test Tonic â€“ a rapid test system for the malaria-causing parasite <SPAN style="font-style: italic;">Plasmodium</SPAN></H3><DIV>
                Malaria is a widely spread infectious disease that causes 
                400.000 deaths every year and affects more than 200 million 
                people in total according to the WHO's Worlds Malaria Report 2017. 
                The disease is caused by different species of the protozoan parasite <I>Plasmodium</I>. 
                For a successful therapy of Malaria, a fast and sensitive 
                detection of the species affecting the patient is crucial.
                <SUP><A href="#desc_refs">1</A></SUP>
                
                Our aim is to construct a test system that is capable of 
                detecting the DNA of <I>Plasmodium</I>. 
                We venture to create a rapid, easily usable and cheap diagnostic 
                device for large area application. To reach this goal,
                we design primers and probes by analysing published sequences
                of the human pathogenic <I>Plasmodium</I> species with bioinformatic tools.
                We reach out to create one primer-probe pair that can detect <I>Plasmodium</I> 
                in general and a specific primer/probe pair for <I>P. falciparum</I>.
                
                
                
                For the amplification of characteristic parts of the <I>Plasmodium</I> 
                genome we developed two pairs of primers for each species. 
                One of these indicates if a patient is affected of <I>Plasmodium</I> in general. 
                The other one specifically detects the species <I>Plasmodium falciparum</I>.
                
                
                
                After identification of fitting sequences, 
                we evaluate and optimize our primers by running qPCR assays with 
                E. coli containing our BioBrick: a plasmid with a short, 
                synthetic, non-pathogenic sequence of the <I>Plasmodium</I> genome 
                as a positive control. Additionally we conduct qPCR assays 
                with genomic DNA of cultured <I>Plasmodium</I> parasites.
                
                
               
                To perform the amplification directions in a user-friendly 
                way we designed a hardware model. The reactions steps are conducted
                in a simple test tube with separated chambers to isolate different reactions. 
                A step motor and an Arduino manage the movement and mixing of the reaction fluids. 

                
                
                After creating a fundamental model with a multiplex qPCR we elaborate 
                a way to apply our detection system to Recombinase Polymerase Amplification 
                (RPA)<SUP><A href="#desc_refs">2</A></SUP>, 
                <SUP><A href="#desc_refs">3</A></SUP>. RPA is a promising alternative for qPCR 
                to isothermally amplify our target sequences in a short period of time. 
                It has been shown to be a sufficient method to detect 
                Plasmodium DNA by Kersting et al. in 2014<SUP><A href="#desc_refs">4</A></SUP>. 
                RPA makes such a test system cheap and avoids the 
                need of an expensive thermocycler. This results in many advantages 
                for the application in travelling situations and in areas without
                proper infrastructure and energy supply.

                <H5 id="collabs_refs">List of References</H5><SUP>1</SUP><A href="http://www.who.int/malaria/areas/treatment/overview/en/">http://www.who.int/malaria/areas/treatment/overview/en/</A><SUP>2</SUP><A href="https://www.ncbi.nlm.nih.gov/pubmed/27160000">https://www.ncbi.nlm.nih.gov/pubmed/27160000</A><SUP>3</SUP><A href="https://reader.elsevier.com/reader/sd/pii/S0165993617302583?token=AE0F18E7C2136EF7A427BAE926122837FF1300E42C71ECC9B6E963D576D6DA841786904CC29F16458D3472BC66EF6B7F">https://reader.elsevier.com/reader/sd/pii/S0165993617302583</A><SUP>4</SUP><A href="https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-13-99">https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-13-99</A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>